Perigard-D 4mg/1.25mg Tablet
Prescription Required
Introduction of Perigard-D Tablet
Perigard-D 4mg/1.25mg Tablet is a medicine used to treat hypertension (high blood pressure). It is a combination of two medicines that helps to control blood pressure when a single medication is not effective. It helps to reduce the chances of any future heart attack and stroke.
Perigard-D 4mg/1.25mg Tablet is a combination of an antihypertensive and a diuretic medicine.
Perigard-D 4mg/1.25mg Tablet is a combination of an antihypertensive and a diuretic medicine.
Uses of Perigard-D Tablet
Benefits of Perigard-D Tablet
In Hypertension (high blood pressure)
Perigard-D 4mg/1.25mg Tablet relaxes the blood vessels so that blood can flow more easily around your body. It also eliminates excess water from the body and increases urine output. This lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should take it regularly as prescribed for this medicine to be most effective, even if you feel better.
Side effects of Perigard-D Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youโre worried about them
Common side effects of Perigard-D
- Nausea
- Diarrhea
- Stomach pain
- Constipation
- Vomiting
- Headache
- Vertigo
- Dizziness
- Altered vision
- Numbness
- Ringing in ear
- Breathlessness
- Indigestion
- Allergic reaction
- Skin rash
- Itching
- Cramps
- Fatigue
How to use Perigard-D Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Perigard-D 4mg/1.25mg Tablet is to be taken empty stomach.
Safety advice
Alcohol
UNSAFE
Perigard-D 4mg/1.25mg Tablet may cause excessive drowsiness with alcohol.
Pregnancy
CONSULT YOUR DOCTOR
Perigard-D 4mg/1.25mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Perigard-D 4mg/1.25mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Perigard-D 4mg/1.25mg Tablet may cause side effects which could affect your ability to drive.
Perigard-D 4mg/1.25mg Tablet usually does not affect alertness but dizziness or weakness due to low blood pressure may occur in some patients. This may affect your driving ability.
Perigard-D 4mg/1.25mg Tablet usually does not affect alertness but dizziness or weakness due to low blood pressure may occur in some patients. This may affect your driving ability.
Kidney
CAUTION
Perigard-D 4mg/1.25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Perigard-D 4mg/1.25mg Tablet may be needed. Please consult your doctor.
Caution should be advised in patients with renal impairment.
Caution should be advised in patients with renal impairment.
Liver
CAUTION
Perigard-D 4mg/1.25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Perigard-D 4mg/1.25mg Tablet may be needed. Please consult your doctor.
What if you forget to take Perigard-D Tablet?
If you miss a dose of Perigard-D 4mg/1.25mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Perigard-D 4mg/1.25mg Tablet
โน9.89/Tablet
Coversyl Plus Tablet
Serdia Pharmaceuticals India Pvt Ltd
โน19.25/tablet
95% costlier
Eviper D 4 mg/1.25 mg Tablet
Torrent Pharmaceuticals Ltd
โน10.9/tablet
10% costlier
Perindosyl Plus 4mg/1.25mg Tablet
Elder Pharmaceuticals Ltd
โน17/tablet
72% costlier
Coveril-Plus Tablet
Johnlee Pharmaceuticals Pvt Ltd
โน15.9/tablet
61% costlier
Rindopril D 4mg/1.25mg Tablet
ADN Life Sciences
โน17.3/tablet
75% costlier
Quick tips
Perigard-D Tablet
- You have been prescribed Perigard-D 4mg/1.25mg Tablet for the treatment of high blood pressure.
- It also lowers your risk of stroke and heart attack.
- Perigard-D 4mg/1.25mg Tablet may cause dizziness or sleepiness. Don't drive or do anything requiring concentration until you know how it affects you.
- To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.
- Inform you doctor about any cough, or throat irritation that doesn't go away.
- Perigard-D 4mg/1.25mg Tablet may cause dehydration. Drink plenty of fluids and Inform your doctor if you develop extreme thirst, muscle weakness or very dry mouth.
- Your doctor may regularly monitor your blood pressure, kidney function and the levels of salts such as potassium in your blood while you are taking this medicine.
- Do not take Perigard-D 4mg/1.25mg Tablet if youโre pregnant or planning pregnancy. It can cause birth defects or be fatal to your unborn baby.
Fact Box
Habit Forming
No
Therapeutic Class
CARDIAC
Patient concerns
Patient concerns
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Perindopril erbumine+Indapamide. Boucherville, (QC), Canada: Sandoz Canada Inc.; 2018. [Accessed 11 Apr. 2019] (online) Available from:
- Perindopril arginine+indapamide. Wicklow, Ireland: Servier (Ireland) Industries Ltd.; 2018. [Accessed 11 Apr. 2019] (online) Available from:
Marketer details
Name: Glenmark Pharmaceuticals Ltd
Address: Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai โ 400 026.
Country of origin: India
Lab tests offered by us
Related/Popular tests
310 people viewed this recentlyDISCONTINUED
We do not facilitate sale of this product at present